The research from the Getzoff and Tainer labs suggests a new approach to developing therapies for ALS.
The findings from the Teyton lab could lead to novel approaches to diseases such as type 1 diabetes as well as new ways to boost the effectiveness of vaccines.
The effort, led by the Oldstone lab, aims to uncover how the virus causes disease, as well as why some patients die while others survive.
Meet Dana Scoville of Counseling and Psychological Services, Scripps Florida.